Medicenna Therapeutics (MDNA.TO) reported Tuesday that the first patient has been dosed in a Phase 1

With Canadian retail sales showing a modest increase and central banks holding interest rates steady, the market is navigating through a period of cautious optimism. In such conditions, investors often look to smaller or newer companies for opportunities, and penny stocks—despite their old-fashioned name—can offer surprising value when paired with strong financial foundations. This article highlights three penny stocks that stand out for their financial strength, offering potential stability...

Medicenna Therapeutics (MDNA.TO), trading near 52 week lows, on Tuesday presented new "positive" pre

The Canadian market has recently experienced some positive shifts, with the unemployment rate showing signs of stabilization and inflation gradually easing. In such a landscape, investors often look for opportunities that balance potential growth with financial stability. Penny stocks, while an older term, still represent a viable investment area by spotlighting smaller or less-established companies that may offer significant value. By focusing on those with strong fundamentals and promising...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Medicenna Therapeutics (MDNA.TO) said Thursday its lead candidate MDNA-11 is being tested with two m

The Canadian market has shown resilience, closing October near record highs despite potential disruptions from geopolitical tensions and central bank policies. In such a climate, investors often look for opportunities in less conventional areas like penny stocks—an outdated term that still signifies smaller or newer companies with potential growth. By focusing on those with strong financials, investors may find promising opportunities among these under-the-radar stocks.

In Canada, recent economic indicators show signs of stabilization, with the labor market steadying and inflation metrics aligning with expectations. As the broader stock market experiences a period of momentum and potential volatility, investors might find opportunities in lesser-known areas like penny stocks. Although considered niche today, penny stocks can offer significant growth potential when they are backed by strong financial fundamentals.

Medicenna Therapeutics (MDNAF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).